James D. Swift - 01 Jun 2024 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role: Chief Executive Officer, Director
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Issuer symbol: MD
Transactions as of: 01 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2024, 17:00:13 UTC
Previous filing: 05 Mar 2024
Next filing: 03 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Award	$0	+105,165	+138%	$0.000000	181,101	01 Jun 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan.

Content

Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan.